Real World Data and Real World Evidence to Support Regulatory Decision Making for Drug and Biological Products – FDA Draft Guidance
Use of Real World Data and Real World Evidence to Support Regulatory Decision Making for Drug and Biological Products
FDA issued the draft guidance as part of its Real World Evidence (RWE) Program...
Drug and Biological Products, FDA Draft Guidance, Real-World Data, Real-World Evidence